Amphotericin B Conventional Injectable: Dosing and Safety
Conventional amphotericin B guidance for cryptococcal meningitis induction and severe systemic fungal infections, with major renal-toxicity precautions.
Also searched as
Source reviewed
March 2024
Guide category
Injectable drugs
Safety boundary
Prescription medicine information for clinician-guided use.
Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.
Therapeutic action
Antifungal.
Indications
- Cryptococcal meningitis induction phase, in combination with flucytosine or fluconazole.
- Severe histoplasmosis or penicilliosis.
Forms and strengths, route of administration
- Powder for injection, in 50 mg vial, dissolved in 10 ml water for injection to obtain a concentrated solution containing 5 mg/ml.
- The concentrated solution must be diluted in 500 ml of 5% glucose to obtain a solution containing 0.1 mg/ml, for slow IV infusion.
Dose
- Child and adult: 0.7 to 1 mg/kg once daily over 4 to 6 hours depending on tolerance.
Duration
- Cryptococcal meningitis: one week if in combination with flucytosine, or 2 weeks if in combination with fluconazole.
- Histoplasmosis: 1 to 2 weeks.
- Penicilliosis: 2 weeks.
Contra-indications, adverse effects, precautions
- Due to numerous and potentially severe adverse effects, patients should be kept under close surveillance.
- Administer with caution to patients with renal impairment.
- May cause intolerance reactions during administration, local thrombophlebitis, allergic reactions, muscle or joint pain, cardiovascular disorders, neurologic disorders, haematological or hepatic disorders, and renal-function disturbances including hypokalaemia and hypomagnesiemia.
- Avoid combination with drugs causing hypokalaemia, nephrotoxic drugs, digoxin, and zidovudine.
- To prevent renal toxicity, administer 500 ml to 1 litre of 0.9% sodium chloride or Ringer lactate prior to each infusion.
- Monitor serum creatinine and, if possible, serum potassium throughout treatment.
- If renal function deteriorates, increase preventive hydration or stop treatment, then resume at the lowest effective dose or on alternate days after improvement.
- Pregnancy: check for renal dysfunction in the neonate if administered during the last month of pregnancy.
- Breast-feeding: avoid, except if vital.
- Only use 5% glucose for administration and do not add other drugs in the infusion bottle or bag.
Source
MSF Essential drugs practical guidelines (January 2026)
This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.
Rate this guide
Be the first to rate this guide.
